Tech Giants Expand in AI Drug Development Through Deals and New Products
Anthropic announced that it acquired Mithril Medicine. [[fact-sev2r3lta]] Mithril founder Cody Tranbarger used Claude to coordinate 11 external laboratories, advance a potential therapy into the experimental stage, and achieve positive results in mice. [[fact-90gm32n6f]] Isomorphic Labs completed a $2.1 billion Series B led by Thrive Capital, with Alphabet, GV, Temasek and others participating. [[fact-dbbj2w5so]] Novo Nordisk and Amazon announced a strategic partnership and established an AI joint innovation center in London. [[fact-5xlgc98ro]] Microsoft Discovery became available to enterprises in June 2026. [[fact-r4fb8o69s]] OpenAI launched GPT-Rosalind for biology, drug discovery and translational medicine on April 16, 2026. [[fact-t8fd09464]]